214 Shares in ICU Medical, Inc. (NASDAQ:ICUI) Purchased by Harvest Fund Management Co. Ltd

Harvest Fund Management Co. Ltd purchased a new stake in ICU Medical, Inc. (NASDAQ:ICUI) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 214 shares of the medical instruments supplier’s stock, valued at approximately $33,000.

A number of other hedge funds have also added to or reduced their stakes in ICUI. Point72 Hong Kong Ltd bought a new position in shares of ICU Medical in the third quarter valued at approximately $72,000. Venturi Wealth Management LLC lifted its stake in ICU Medical by 64.0% during the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier’s stock valued at $82,000 after acquiring an additional 206 shares in the last quarter. Smartleaf Asset Management LLC boosted its holdings in ICU Medical by 166.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier’s stock worth $140,000 after acquiring an additional 567 shares during the last quarter. Coldstream Capital Management Inc. bought a new stake in shares of ICU Medical in the 3rd quarter worth $227,000. Finally, OLD National Bancorp IN raised its holdings in shares of ICU Medical by 22.0% in the fourth quarter. OLD National Bancorp IN now owns 1,462 shares of the medical instruments supplier’s stock valued at $227,000 after purchasing an additional 264 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

ICU Medical Trading Down 0.7 %

Shares of ICUI stock opened at $147.07 on Monday. The company’s fifty day simple moving average is $156.08 and its two-hundred day simple moving average is $164.43. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The stock has a market capitalization of $3.61 billion, a price-to-earnings ratio of -32.18 and a beta of 0.73. ICU Medical, Inc. has a 1 year low of $93.36 and a 1 year high of $196.26.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Raymond James set a $97.00 price objective on shares of ICU Medical in a research report on Wednesday, March 12th. StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research note on Tuesday, March 18th. Finally, Jefferies Financial Group upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a research note on Wednesday, December 11th. One investment analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $168.67.

Insider Activity

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total value of $213,474.04. Following the sale, the chief executive officer now owns 104,593 shares of the company’s stock, valued at $16,262,119.64. This trade represents a 1.30 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 6.70% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.